Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
17.1M
-
Shares change
-
-277K
-
Total reported value, excl. options
-
$54.2M
-
Value change
-
-$890K
-
Number of buys
-
34
-
Number of sells
-
-35
-
Price
-
$3.18
Significant Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q3 2022
82 filings reported holding STIM - Neuronetics, Inc. - Common Stock, par value $0.01 per share as of Q3 2022.
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.1M shares
of 66M outstanding shares and own 25.87% of the company stock.
Largest 10 shareholders include CANNELL CAPITAL LLC (3.46M shares), Archon Capital Management LLC (1.83M shares), VANGUARD GROUP INC (1.15M shares), Parian Global Management LP (830K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (796K shares), SCHRODER INVESTMENT MANAGEMENT GROUP (738K shares), Millrace Asset Group, Inc. (645K shares), Brandywine Global Investment Management, LLC (504K shares), First Washington CORP (460K shares), and BlackRock Inc. (416K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.